Unknown

Dataset Information

0

Immune checkpoint inhibitor-induced bullous pemphigoid is characterized by interleukin (IL)-4 and IL-13 expression and responds to dupilumab treatment.


ABSTRACT:

SUBMITTER: Shipman WD 

PROVIDER: S-EPMC10947518 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Immune checkpoint inhibitor-induced bullous pemphigoid is characterized by interleukin (IL)-4 and IL-13 expression and responds to dupilumab treatment.

Shipman William D WD   Singh Katelyn K   Cohen Jeffrey M JM   Leventhal Jonathan J   Damsky William W   Tomayko Mary M MM  

The British journal of dermatology 20230801 3


Similar Datasets

| S-EPMC10071969 | biostudies-literature
| S-EPMC10398542 | biostudies-literature
| S-EPMC10512848 | biostudies-literature
| S-EPMC8552038 | biostudies-literature
| S-EPMC8818855 | biostudies-literature
| S-EPMC10421662 | biostudies-literature
| S-EPMC11651321 | biostudies-literature
| S-EPMC9188788 | biostudies-literature
| S-EPMC4227922 | biostudies-literature